Stocktoria
ADMA BIOLOGICS, INC. ADMA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2013-10-17
ADMA BIOLOGICS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 18,644,711 | $208.4M | 7.61% |
| CITADEL ADVISORS LLC | 6,247,242 | $56.3M | 2.55% |
| MILLENNIUM MANAGEMENT LLC | 3,434,449 | $30.9M | 1.4% |
| Point72 Asset Management, L.P. | 3,309,657 | $29.8M | 1.35% |
| TWO SIGMA INVESTMENTS, LP | 2,092,133 | $18.9M | 0.85% |
| RENAISSANCE TECHNOLOGIES LLC | 1,262,634 | $11.4M | 0.52% |
| D. E. Shaw & Co., Inc. | 560,827 | $5.1M | 0.23% |
| AQR CAPITAL MANAGEMENT LLC | 514,789 | $4.6M | 0.21% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.